Equities
Health CarePharmaceuticals & Biotechnology
  • Price (EUR)36.60
  • Today's Change1.00 / 2.81%
  • Shares traded20.06k
  • 1 Year change-2.79%
  • Beta0.6022
Data delayed at least 15 minutes, as of Dec 02 2021 16:35 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Boiron SA is a France-based pharmaceutical company engaged in the provision of homeopathic medicines. The Company develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. It also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.

  • Revenue in EUR (TTM)449.88m
  • Net income in EUR17.67m
  • Incorporated1967
  • Employees3.23k
  • Location
    Boiron SA2 avenue de l ouest LyonnaisRONTALON 69510FranceFRA
  • Phone+33 478456100
  • Fax+33 478456291
  • Websitehttp://www.boiron.fr/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Innate Pharma SA34.62m-77.37m366.77m212.00--2.74--10.59-0.98-0.980.43861.690.1155--17.01141,877.00-25.82-6.92-32.62-10.0088.5893.94-223.49-39.97---27.050.3186---18.5925.68-208.22--60.28--
Cellectis SA61.96m-112.87m380.74m340.00--1.81--6.14-2.56-2.561.424.620.1562--31.99182,241.70-31.55-22.99-38.71-28.53---18.04-201.92-217.464.72-30.940.2852--258.665.6820.59--62.49--
Abivax SA0.00-38.66m425.65m29.00---------2.48-2.480.00-0.30470.00----0.00-73.70-37.26-160.24-48.72--------0.6267-17.821.16-------22.58---2.61--
Carbios SA832.00k-8.30m428.94m39.00--2.79--515.55-0.8265-0.82650.082613.770.00852.301.7226,838.71-8.44-9.65-8.81-10.3789.06---997.72-87.5521.72-118.020.0351---7.179.97-63.94--39.04--
Guerbet SA711.76m32.90m449.92m2.64k13.741.165.040.63212.602.6056.1430.750.73950.79145.70270,116.503.423.544.405.0575.9675.984.624.541.264.320.461328.04-12.817.82-52.55-14.7012.351.49
AB Science SA1.59m-10.90m574.49m96.00------360.41-0.2253-0.22530.0331-0.27250.0624-0.04084.5817,326.09-42.66-73.56-575.20-189.51100.5086.77-683.81-1,452.391.08--163.58--0.7638-7.0730.82---9.75--
Boiron SA449.88m17.67m624.62m3.23k35.271.2712.141.391.011.0125.6927.940.60311.385.98134,533.502.377.323.079.2174.6778.193.939.642.0278.560.020943.78-7.82-3.31-35.49-18.73-4.49-8.73
Data as of Dec 02 2021. Currency figures normalised to Boiron SA's reporting currency: Euro EUR

Institutional shareholders

12.77%Per cent of shares held by top holders
HolderShares% Held
Natixis Investment Managers International SAas of 31 Dec 2020995.37k5.67%
Financi�re de l'�chiquier SAas of 31 Dec 2020445.80k2.54%
Sycomore Asset Management SAas of 30 Sep 2021199.93k1.14%
Norges Bank Investment Managementas of 31 Dec 2020160.34k0.91%
BlackRock Fund Advisorsas of 04 Nov 2021102.32k0.58%
Dimensional Fund Advisors LPas of 04 Nov 202193.81k0.54%
The Vanguard Group, Inc.as of 31 Oct 202178.58k0.45%
SMA Gestion SAas of 30 Jun 202075.56k0.43%
Fidelity Management & Research Co. LLCas of 30 Sep 202164.42k0.37%
Fidecum AGas of 30 Jul 202123.50k0.13%
More ▼
Data from 30 Jun 2020 - 30 Sep 2021Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.